Ingredient or product comparison
Quickcomparison
Dose Range GHK-Cu 1–3 mg Copper Tripeptide-1 (GHK-Cu) 0.01%–1% % Frequency Once daily Administration Subcutaneous injection Topical Cycle Length 8-12 weeks Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level Strong preclinical (extensive animal
This source-based comparison does not add ratings or recommend a winner.
- Dose Range
- GHK-Cu
- 1–3 mg
- Copper Tripeptide-1 (GHK-Cu)
- 0.01%–1% %
- Frequency
- Once daily
- Administration
- Subcutaneous injection
- Topical
- Cycle Length
- 8-12 weeks
- Ongoing/indefinite
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Strong preclinical (extensive animal studies)
- Limited human trials
- Efficacy